image credit: Unsplash

Elastrin Therapeutics Develops Humanized Antibody to Treat COVID-19-Related Issues

On March 26, 2020, Elastrin Therapeutics, a biotech startup, announced it has developed the world’s first humanized antibody that targets exposed elastin fiber that leads to impaired lung function, and is currently pursuing investments to further development. The antibody will be used to treat respiratory conditions related to COVID-19 infection.

According to a company press release, many COVID-19 patients have a pre-existing condition that destroys elastic fiber, which is necessary for air sacs and blood vessels to deliver oxygen and blood.

Read More on Biopharm International